Concepedia

Author

Mark Ringhoffer

Städtisches Klinikum Karlsruhe

Also Known As

A Kündgen, G Held, M Ringhoffer, M. Ringhoffer, MARK RINGHOFFER, Mark Ringhoffer

135

Publications

6.7K

Citations

41

H-Index

56

Concepts

All Affiliations

Städtisches Klinikum KarlsruheJohannes Gutenberg University MainzUniversität UlmUniversity Hospital UlmHeinrich Heine University Düsseldorf
MR

About

Mark Ringhoffer is an author at Städtisches Klinikum Karlsruhe specializing in medicine, immunology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

21

1.9K

2

Cell Biology

10

11

1K

3

Health Sciences

3

4

236

4

Natural Sciences

1

1

10

5

Allergy

1

1

21

Mark Ringhoffer

×

55

Publications

6.3K

Citations

38

H-Index

YearCitations

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

Elke Jäger, Yao-Tseng Chen, Jan W. Drijfhout,

The Journal of Experimental Medicine

1998

722

Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation

Richard F. Schlenk, Sabine Käyser, Lars Bullinger,

Blood

2014

394

Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

Elke Jäger, Mark Ringhoffer, M. Altmannsberger,

International Journal of Cancer

1997

305

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptidesin vivo

Elke J�ger, Mark Ringhoffer, Hans Peter Dienes,

International Journal of Cancer

1996

296

Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

Richard F. Schlenk, Daniela Weber, Walter Fiedler,

Blood

2018

283

Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: Evidence for immunoselection of antigen-loss variantsin vivo

Elke Jäger, Mark Ringhoffer, Julia Karbach,

International Journal of Cancer

1996

270

RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features

Verena I. Gaidzik, Veronica Teleanu, Elli Papaemmanuil,

Leukemia

2016

264

Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptidesin vivo: Implications for tumor vaccines with melanoma-associated antigens

E. Jaeger, Helga Bernhard, Pedro Romero,

International Journal of Cancer

1996

244

Adoptive transfer and selective reconstitution of streptamer‐selected cytomegalovirus‐specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

Anita Schmitt, Torsten Tonn, Dirk H. Busch,

Transfusion

2010

216

RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses

Michael Schmitt, Anita Schmitt, Markus Rojewski,

Blood

2007

211

Page 1